Clinical Trial Update: Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing neoadjuvant letrozole plus metformin versus letrozole plus placebo in ER-positive postmenopausal breast cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• metformin (metformin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hormone Receptor Positive Malignant Neoplasm of Breast | Phase 2 | Status: COMPLETED